Michael Botticelli, acting director of the Office of National Drug Control Policy (ONDCP) and a longtime friend of medication-assisted treatment (MAT), dating from his years heading the Massachusetts Bureau of Substance Abuse Services, gave AT Forum an exclusive interview this summer on how opioid treatment programs (OTPs) effectively treat their patients who have opioid use … [Read more...] about ONDCP’s Michael Botticelli on the Importance of OTPs in Treating Opioid Use Disorders
There are big changes coming up for opioid treatment programs (OTPs) and other substance use disorder (SUD) programs in New York State. Starting next year, the longstanding fee-for-service Medicaid reimbursement system will be replaced by managed care; also starting next year, new insurance legislation to protect SUD patients is expected to be enacted. Henry Bartlett, … [Read more...] about Medicaid Managed Care, New Insurance Rules Coming to New York Opioid Treatment Programs
The sharp rise in heroin use and prescription opioid abuse in recent years underscores the need for effective treatment for opioid addiction. Yet previous studies have shown that most methadone maintenance treatment (MMT) programs—the primary treatment for opioid use disorders—haven’t provided doses that meet evidence-based standards, 80 mg/day and above. Evidence-based … [Read more...] about Research Report: Dosage Trends in Methadone Maintenance Treatment Programs: Significant Improvement, But Still Below Evidence-Based Standards
A study published online May 12, 2014 in Substance Abuse compared demographic characteristics and treatment outcomes of 252 patients enrolling in a methadone maintenance treatment (MMT) program with those of 252 buprenorphine patients starting treatment in an internal medicine practice affiliated with a medical school. The authors planned the study as “a real-life … [Read more...] about Research Report: Patients Treated With Methadone vs. Buprenorphine: Differences in Demographic Characteristics and Treatment Outcomes
The daily worries and instabilities that plague opioid-dependent patients can make it difficult for providers to deliver effective long-term substance-abuse and medical treatment. Lack of information about patients’ life concerns leaves providers without direction about key issues that may cause patients to leave treatment. In the first study to classify life concerns in … [Read more...] about Life Concerns of Prescription Opioid and Heroin Users—What Are They, and How Do They Differ?